Know Cancer

or
forgot password

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.


Phase 1
N/A
N/A
Open (Enrolling)
Both
Hyperparathyroidism

Thank you

Trial Information

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.


Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in
increased levels of calcium in the blood stream, which can lead to weakening of the bones
and to kidney stones.

We are postulating that the non-invasive energy specific electromagnetic radiation of the
central nervous system, the viscera and the endocrine system has the potential to stop the
over secretion of the parathyroid hormones and normalize the body's metabolic functions.


Inclusion Criteria:



- Persons with parathyroid disease

Exclusion Criteria:

- None

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

The primary end point is to determine the therapeutic effects of far infrared radiation on Hyperparathyroidism.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Ken Nedd, M.D.

Investigator Role:

Study Director

Investigator Affiliation:

GAAD Medical Research Institute Inc.

Authority:

Canada: Health Canada

Study ID:

GAAD-HT-CTP1

NCT ID:

NCT00573573

Start Date:

January 2007

Completion Date:

July 2009

Related Keywords:

  • Hyperparathyroidism
  • PRIMARY HYPERPARATHYROIDISM
  • PARATHYROID NEOPLASMS
  • SECONDARY HYPERPARATHYROIDISM
  • HYPOCALCEMIA
  • Hyperparathyroidism

Name

Location